Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Furen Hengfeng Pharmaceutical is a Chinese pharmaceutical company based in Shanxi Province and operates as a subsidiary of the Furen Pharmaceutical Group. The company specializes in the manufacturing and distribution of a wide range of healthcare products, including chemical generic drugs and traditional Chinese medicine (TCM) preparations. Its product portfolio primarily addresses common therapeutic areas such as respiratory, digestive, and cardiovascular health. While its parent company has recently undergone significant financial restructuring and delisting from the Shanghai Stock Exchange, Shanxi Furen Hengfeng continues to serve as a regional production and supply hub within the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Furen Hengfeng Pharmaceutical.